GE HealthCare has launched the Invenia Automated Breast Ultrasound (ABUS) Premium, a 3D ultrasound offering advanced AI features to drive faster, reproducible screening and streamline exam...
AbbVie has announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE (mirvetuximab soravtansine-gynx) in women with folate...
A new study has revealed that the HER2DX diagnostics test impacts clinical decision making in early-stage HER2-positive breast cancer, leading to modifications in treatment plans. Developed...
Researchers have identified a novel trigger of a deadly form of ovarian cancer: a subset of progenitor cells that reside in fallopian tube supportive tissue, or...
In a new study, IgE antibodies have been shown to help activate monocytes – a type of immune cell – making them more effective at attacking...
Breast density plays a significant role in both the risk of breast cancer diagnosis and the sensitivity of mammography, which may affect screening practices, new research...
Among postmenopausal women with a history of cancer, taking more daily steps and engaging in moderate-to-vigorous physical activity were both associated with a significantly reduced risk...
A new study helps explain why Triple-negative breast cancer patients with obesity-driven diabetes often have worse outcomes, and suggests a potential way to improve treatment for...
By Steven Chen, chief medical Officer at medtech firm ImpediMed. As cancer survival rates continue to climb, healthcare providers must address a critical yet often overlooked...
Despite similar availability of diagnostic technologies to women of different racial and ethnic groups, significant disparities were seen in who actually received same-day diagnostic services and...
